Hayes, Inc., an independent health technology research and consulting company dedicated to promoting better health outcomes, has announced it will provide evidence-based health technology assessments to three major international healthcare concerns.
Specifically, Hayes has been chosen by the Ministry of Health in Basque Country, an autonomous community in the Kingdom of Spain, to support evidence based decisions on new health technologies.
As per the appointment, Hayes will help the Basque Office for Health Technology Assessment to support its initiative to improve patient care and outcomes, and to make evidence-based decisions about new healthcare technology purchases.
Dr. Iñaki Gutiérrez Ibarluzea of the Basque Ministry of Health, cites information collected from a 2008 funded project of the Spanish Network of Agencies for Health Technology Assessment. The research revealed that there are differences between the efficiency of the information sources to be consulted when trying to identify new and emerging health technologies.
“Hayes was consistently among the top information sources for technologies such as devices, diagnostics, drugs, public health interventions and procedures and accordingly we chose Hayes as a valuable tool in our daily work as a Health Technology Assessment agency.”
Hayes has also been chosen by the Hospital Israelita Albert Einstein (HIAE) in Sao Paolo, Brazil to support its decision-making process for the acquisition of new health technologies. Camila Sardenberg, MD, Medical Practice Manager of Hospital Israelita Albert Einstein says they selected Hayes for their ability to offer a broad, unbiased and sophisticated analysis on emerging health technologies that helps them reach their goal of promoting continuous improvement in medical practice, by establishing evidence-based standards centered in patient safety.
Helsana, Switzerland’s major health insurer will also use Hayes Technology Prognosis, a horizon-scanning service that provides hospitals, insurers, and policy makers with a forward-looking view of the changing health technology landscape. Hayes will enable Helsana to stay abreast of emerging healthcare technologies and to create actuarial models for calculation of future healthcare costs.
Anuradha Shukla is a contributing editor for HealthTechZone. To read more of Anuradha’s article, please visit her columnist page.Edited by
Stefania Viscusi
